TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18509656

Group type: EXPERIMENTAL
Intervention: Group A: 100 mL of 300 mg I/mL at 5.0 mL/s
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Group B: 100 mL of 350 mg I/mL at 5.0 mL/s
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Group C: 100 mL of 300 mg I/mL at 3.5 mL/s
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Group D: 100 mL of 350 mg I/mL at 3.5 mL/s
Number of subjects: 80
Study: 15861762

Group type: EXPERIMENTAL
Intervention: Instillation of water for 15 minutes before syringing
Number of subjects: 26

Group type: COMPARATOR
Intervention: Immediate syringing
Number of subjects: 26
Study: 12204703

Group type: EXPERIMENTAL
Intervention: 0.005% latanoprost once daily (n = 737)
Number of subjects: 1389

Group type: COMPARATOR
Intervention: 0.5% timolol twice daily (n = 652)
Number of subjects: 1389
Study: 10480616

Group type: EXPERIMENTAL
Intervention: Acipimox (250 mg)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 8739541

Group type: EXPERIMENTAL
Intervention: Pentoxifylline 600 mg intravenously twice a day
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 1607532

Group type: EXPERIMENTAL
Intervention: 100 mg/2 h of rt‐PA (Activase)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 3 million U/2 h of urokinase (Abbokinase)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 90
Study: 6242148

Group type: EXPERIMENTAL
Intervention: 2 micrograms subcutaneously
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: 2 micrograms intradermally
Number of subjects: 197

Group type: COMPARATOR
Intervention: Hevac B (placebo-treated carriers)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Booster vaccination of initial non‐responders
Number of subjects: 197
Study: 30886069

Group type: EXPERIMENTAL
Intervention: Proximal ultrasound-guided GON block with bupivacaine and methylprednisolone acetate
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Distal ultrasound-guided GON block with bupivacaine and methylprednisolone acetate
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Proximal ultrasound-guided GON block
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Distal ultrasound-guided GON block
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both techniques
Number of subjects: 40
Study: 29724165

Group type: EXPERIMENTAL
Intervention: Twice-weekly supervised exercise sessions and nutritional counselling (n=303)
Number of subjects: 589

Group type: COMPARATOR
Intervention: Standard prenatal care (n=303)
Number of subjects: 589
Study: 26438574

Group type: COMPARATOR
Intervention: 4-valent HPV vaccination program
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: 9-valent HPV vaccination program
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Switching to a 9-valent gender-neutral program
Number of subjects: 2
Study: 25208688

Group type: EXPERIMENTAL
Intervention: SMART™ CONTROL stent
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: COMPLETE™‐SE stent
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Aspirin plus clopidogrel
Number of subjects: 346

Group type: COMPARATOR
Intervention: Aspirin plus cilostazol
Number of subjects: 346
Study: 21811291

Group type: COMPARATOR
Intervention: Control low-fat milk
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Cream
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Butter
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Cheese
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Yoghurt
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Non-fermented dairy diet (butter, cream, ice cream)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Fermented dairy diet (cheese, yoghurt)
Number of subjects: 13
Study: 20184573

Group type: EXPERIMENTAL
Intervention: TURP
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: CLP
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: EVAP
Number of subjects: 150

Group type: COMPARATOR
Intervention: TURP, CLP, EVAP
Number of subjects: 150
Study: 17949573

Group type: EXPERIMENTAL
Intervention: Clinical practice guideline treatment by trained family doctors
Number of subjects: 419

Group type: COMPARATOR
Intervention: Control group treatment by family doctors unaware of the guideline
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Clinical practice guideline treatment
Number of subjects: 419

Group type: COMPARATOR
Intervention: Control group treatment
Number of subjects: 419
Study: 16112646

Group type: EXPERIMENTAL
Intervention: Testis cDNA library immunoscreening with sera from AML patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RT-PCR analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Real-time PCR (RQ-PCR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antigen presentation assays using mo-DCs
Number of subjects: 0
Study: 11866684

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin (loading dose of 300 mg p.o. followed by 75 mg/day; aspirin 75-325 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin alone (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin
Number of subjects: 0
Study: 10228050

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccination
Number of subjects: 805
Study: 7676769

Group type: EXPERIMENTAL
Intervention: Amicar
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no Amicar)
Number of subjects: 30
Study: 2345255

Group type: EXPERIMENTAL
Intervention: multivitamin
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: multivitamin and iron
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: multivitamin, iron, and zinc
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: multivitamin and zinc
Number of subjects: 90

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 90
Study: 7179191

Group type: EXPERIMENTAL
Intervention: Naftidrofuryl
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 31818675

Group type: EXPERIMENTAL
Intervention: Intermittent energy restriction (IER)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Continuous energy restriction (CER)
Number of subjects: 186
Study: 29901484

Group type: EXPERIMENTAL
Intervention: Health Belief Model Comprehensive Reminder System
Number of subjects: 174

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 174
Study: 26487303

Group type: EXPERIMENTAL
Intervention: Desflurane (3-6%)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sevoflurane (1-2%)
Number of subjects: 52
Study: 25190661

Group type: EXPERIMENTAL
Intervention: Scleral contact lenses with a thick postlens tear layer (Tpost‐tear 350 μm)
Number of subjects: 8
Study: 22357255

Group type: EXPERIMENTAL
Intervention: Nilotinib 400 mg b.i.d.
Number of subjects: 248

Group type: COMPARATOR
Intervention: Best supportive care (BSC)
Number of subjects: 248
Study: 20353107

Group type: EXPERIMENTAL
Intervention: Electroacupuncture; treated at Guanyuan (CV 4), Zhongji (CV 3), Ciliao (BL 32), and Huiyang (BL 35)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Western medicine (Sparfloxacin tablets and Prostat tablets); oral administration
Number of subjects: 48
Study: 17361125

Group type: EXPERIMENTAL
Intervention: Lansoprazole
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Rifampin
Number of subjects: 3
Study: 15841494

Group type: EXPERIMENTAL
Intervention: Mobicox (meloxicam 7.5 mg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Promotion (meloxicam 7.5 mg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Both formulations (Mobicox and Promotion)
Number of subjects: 23
Study: 11926718

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 to 80 mg/day)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study: 9816522

Group type: EXPERIMENTAL
Intervention: Intracoronary brachytherapy with 32P beta-emitter at doses of 16, 20, and 24 Gy
Number of subjects: 0
Study: 7630516

Group type: EXPERIMENTAL
Intervention: bromocriptine + FSH + HMG (Group A)
Number of subjects: 28

Group type: COMPARATOR
Intervention: goserelin depot (Zoladex) + HMG (Group B)
Number of subjects: 28
Study: 2744187

Group type: EXPERIMENTAL
Intervention: Bromocriptine therapy
Number of subjects: 35
Study: 359925

Group type: EXPERIMENTAL
Intervention: 300 mg of Rifampicin daily for 3 months
Number of subjects: 24

Group type: COMPARATOR
Intervention: 50 mg D.D.S. daily for 3 months
Number of subjects: 24
Study: 31322024

Group type: EXPERIMENTAL
Intervention: Muscle Training and Exercise (MTE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adapting Alignment Exercise (AAE)
Number of subjects: 0
Study: 30919998

Group type: EXPERIMENTAL
Intervention: EA-230 (15, 45 and 90 mg/kg/h)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: EA-230 (90 mg/kg/h)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 28432746

Group type: EXPERIMENTAL
Intervention: iGlarLixi (insulin glargine 100 U and lixisenatide)
Number of subjects: 1170

Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 1170
Study: 25808269

Group type: EXPERIMENTAL
Intervention: Family-based treatment (FBT)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Individual adolescent focused therapy (AFT)
Number of subjects: 121
Study: 23558841

Group type: EXPERIMENTAL
Intervention: Distal approach
Number of subjects: 82

Group type: COMPARATOR
Intervention: Tunnel vision approach
Number of subjects: 82
Study: 21774289

Group type: EXPERIMENTAL
Intervention: Intracameral triamcinolone acetonide and gentamicin injections followed by topical tobramycin eye drops four times daily for one week (IC TA group, n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Topical dexamethasone-tobramycin combination eyedrops four times daily until no inflammation was seen (Topical group, n=30)
Number of subjects: 60
Study: 19326828

Group type: EXPERIMENTAL
Intervention: 12-week health promotion course
Number of subjects: 0
Study: 16674744

Group type: EXPERIMENTAL
Intervention: 2.5% NaOCl
Number of subjects: 32

Group type: COMPARATOR
Intervention: 2% CHX gel
Number of subjects: 32
Study: 15296549

Group type: EXPERIMENTAL
Intervention: DMPA (metaphonological abilities development), 91 students
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: DLS (language skills development through active story listening), 65 students
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control group (typical first-grade methods), 46 students
Number of subjects: 202
Study: 11730823

Group type: EXPERIMENTAL
Intervention: Anabolic-androgenic steroids (AAS)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Triptorelin (GnRH agonist)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no hormonal treatment)
Number of subjects: 26
Study: 9229097

Group type: EXPERIMENTAL
Intervention: SICU care after major plastic/reconstructive procedures
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (random cohort)
Number of subjects: 42

Group type: COMPARATOR
Intervention: PACU care for at least 24 hours of perioperative monitoring
Number of subjects: 42
Study: 8431119

Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Cimetidine hydrochloride bolus
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Cimetidine continuous infusion
Number of subjects: 278
Study: 3582476

Group type: EXPERIMENTAL
Intervention: Pentazocine (25 mg)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Aspirin (650 mg)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Meptazinol (100 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Paracetamol (500 and 1000 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Meptazinol (100 and 200 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Pentazocine (25 and 50 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Aspirin (325 and 650 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Triprolidine (10 mg)
Number of subjects: 7
Study: 31558010

Group type: EXPERIMENTAL
Intervention: Proxelan® monotherapy (1 suppository at bedtime for 1 month)
Number of subjects: 30
Study: 29153295

Group type: EXPERIMENTAL
Intervention: 15 mL of 37.5 mg ropivacaine plus 40 mg methylprednisolone (active group, n=49)
Number of subjects: 97

Group type: COMPARATOR
Intervention: 15 mL of saline (placebo group, n=48)
Number of subjects: 97
Study: 27714870

Group type: EXPERIMENTAL
Intervention: School-based educational intervention to reduce verbal bullying; details on dosage and duration not specified.
Number of subjects: 0
Study: 26831423

Group type: EXPERIMENTAL
Intervention: Bentonite cream
Number of subjects: 100

Group type: COMPARATOR
Intervention: Calendula cream
Number of subjects: 100
Study: 23680182

Group type: EXPERIMENTAL
Intervention: Iso‐2·5 GUM
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Iso‐5 GUM
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Iso‐5 LP GUM
Number of subjects: 50

Group type: COMPARATOR
Intervention: Std GUM
Number of subjects: 50
Study: 20609727

Group type: EXPERIMENTAL
Intervention: OR template
Number of subjects: 20

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 20
Study: 18516654

Group type: EXPERIMENTAL
Intervention: Intramedullary tibial cutting guide (Group 1, n=31)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Extramedullary tibial cutting guide (Group 2, n=39)
Number of subjects: 70
Study: 17115273

Group type: EXPERIMENTAL
Intervention: WBOAS-augmented PT/OT care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care alone (Control)
Number of subjects: 0
Study: 15571955

Group type: EXPERIMENTAL
Intervention: Continuous hyperfractionated accelerated radiotherapy (CHART)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Conventionally fractionated radiotherapy
Number of subjects: 309
Study: 11693688

Group type: EXPERIMENTAL
Intervention: Optimized sleep (10 hr.)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Restricted sleep (4 hr.)
Number of subjects: 82
Study: 9418839

Group type: EXPERIMENTAL
Intervention: Lispro insulin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Humulin R
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lispro insulin (open label continuation)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Humulin R (open label continuation)
Number of subjects: 20
Study: 8292434

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser hemorrhoidectomy
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 35
Study: 3549807

Group type: EXPERIMENTAL
Intervention: 2% topical minoxidil
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 3% topical minoxidil
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 2% minoxidil
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 3% minoxidil
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo to 3% minoxidil
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: All groups (2% minoxidil, 3% minoxidil, placebo to 3% minoxidil)
Number of subjects: 150
Study: 30654844

Group type: EXPERIMENTAL
Intervention: Tuina
Number of subjects: 356

Group type: COMPARATOR
Intervention: Traditional Chinese massage
Number of subjects: 356
Study: 29908389

Group type: EXPERIMENTAL
Intervention: Prediction tool based on well-established risk factors (number of previous depressive episodes, residual depressive symptoms, severity of the last depressive episode, treatment)
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: External validation of the prediction tool
Number of subjects: 444
Study: 26867060

Group type: EXPERIMENTAL
Intervention: Olmesartan 20-40 mg/Amlodipine 5-10 mg
Number of subjects: 260

Group type: COMPARATOR
Intervention: Perindopril 4-8 mg/Amlodipine 5-10 mg
Number of subjects: 260
Study: 24330482

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 58

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 58
Study: 22578513

Group type: EXPERIMENTAL
Intervention: Production (PR) procedures
Number of subjects: 14

Group type: COMPARATOR
Intervention: Estimation (EST) procedures
Number of subjects: 14
Study: 19904596

Group type: EXPERIMENTAL
Intervention: Picture Exchange Communication System (PECS)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 36
Study: 17874207

Group type: COMPARATOR
Intervention: Atomoxetine (detailed dosage not specified)
Number of subjects: 328

Group type: COMPARATOR
Intervention: Atomoxetine
Number of subjects: 328
Study: 15503124

Group type: EXPERIMENTAL
Intervention: 60 rpm
Number of subjects: 14

Group type: COMPARATOR
Intervention: 80 rpm
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 100 rpm
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 120 rpm
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Freely Chosen Cadence (FCC)
Number of subjects: 14
Study: 11994249

Group type: EXPERIMENTAL
Intervention: JTT-705 900 mg
Number of subjects: 198
Study: 11939055

Group type: EXPERIMENTAL
Intervention: Selenium (1 mg sodium selenite, one time only)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 2
Study: 7613531

Group type: EXPERIMENTAL
Intervention: Antiandrogen therapy
Number of subjects: 550

Group type: COMPARATOR
Intervention: Castration
Number of subjects: 550
Study: 2167107

Group type: EXPERIMENTAL
Intervention: Naltrexone 25 mg
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Naltrexone 50 mg
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Naltrexone 100 mg
Number of subjects: 4

Group type: COMPARATOR
Intervention: Naltrexone 0 mg (placebo)
Number of subjects: 4
Study: 1256690

Group type: EXPERIMENTAL
Intervention: Diphthalone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Indomethacine
Number of subjects: 10
Study: 30879735

Group type: EXPERIMENTAL
Intervention: Alcohol-free beer with modified carbohydrate composition (16.5 g/day isomaltulose and 5.28 g/day resistant maltodextrin)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Regular alcohol-free beer
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Alcohol-free beer with modified carbohydrate composition
Number of subjects: 41
Study: 28118833

Group type: EXPERIMENTAL
Intervention: EQ-5D (utility)
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: MHQ
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Various PROMs
Number of subjects: 488
Study: 26100349

Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Salmeterol
Number of subjects: 0
Study: 23414499

Group type: EXPERIMENTAL
Intervention: Non‐Hispanic Blacks
Number of subjects: 2063

Group type: EXPERIMENTAL
Intervention: Non‐Hispanic Whites
Number of subjects: 2063

Group type: EXPERIMENTAL
Intervention: Hispanics
Number of subjects: 2063

Group type: EXPERIMENTAL
Intervention: Non‐Hispanic Blacks and Whites
Number of subjects: 2063

Group type: EXPERIMENTAL
Intervention: Non‐Hispanic Whites and Hispanics
Number of subjects: 2063
Study: 21525247

Group type: EXPERIMENTAL
Intervention: Fish oil (FO) (500 mg/d DHA + 150 mg/d EPA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5‐methyltetrahydrofolate (400 μg/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both fish oil and 5‐methyltetrahydrofolate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19257818

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (5 mg) administered within 90 days after surgical repair of an osteoporotic hip fracture
Number of subjects: 2127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2127
Study: 17875874

Group type: EXPERIMENTAL
Intervention: Cold air cooling during and 30 seconds before and after laser irradiation
Number of subjects: 23

Group type: COMPARATOR
Intervention: No cooling (control)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both cooled and uncooled sides
Number of subjects: 23
Study: 15459137

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (500 microg b.i.d. by inhalation and 100 microg intranasally once daily)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (intranasally)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (inhalation)
Number of subjects: 15
Study: 11564611

Group type: EXPERIMENTAL
Intervention: Real water treatment units (WTUs) designed to remove viruses, bacteria, and protozoa.
Number of subjects: 600

Group type: COMPARATOR
Intervention: Sham water treatment units (WTUs).
Number of subjects: 600
Study: 9587120

Group type: EXPERIMENTAL
Intervention: Intratumoral blood flow analysis assessed by color Doppler ultrasound
Number of subjects: 66
Study: 7820981

Group type: EXPERIMENTAL
Intervention: Somatostatin, 100 micrograms subcutaneously at induction of anaesthesia and 8 hourly for 48 h
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 3078526

Group type: EXPERIMENTAL
Intervention: alfentanil 5 micrograms/kg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: fentanyl 1 microgram/kg
Number of subjects: 45

Group type: COMPARATOR
Intervention: no analgesic supplement
Number of subjects: 45
Study: 4998492

Group type: EXPERIMENTAL
Intervention: Scribner shunts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brescia fistulae
Number of subjects: 0
Study: 31644691

Group type: EXPERIMENTAL
Intervention: Unified Protocol (UP) treatment, 20 one-hour sessions
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Unified Protocol (UP) treatment
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 26
Study: 29041563

Group type: EXPERIMENTAL
Intervention: Microlens arrays (MLA) with varying spatial coherence and randomization parameters
Number of subjects: 0
Study: 26082390

Group type: EXPERIMENTAL
Intervention: Cixutumumab plus mitoxantrone and prednisone (MP)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Ramucirumab plus mitoxantrone and prednisone (MP)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control (historical control)
Number of subjects: 132
Study: 24156549

Group type: EXPERIMENTAL
Intervention: Multifaceted tailored implementation strategy including a specific web page and workshops for family physicians and nurses.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard implementation (Control group).
Number of subjects: 0
Study: 21357311

Group type: EXPERIMENTAL
Intervention: Intermittent positive-pressure breathing
Number of subjects: 135

Group type: COMPARATOR
Intervention: Standard physical therapy
Number of subjects: 135